Runda Medical(SH:603108) Xin Lang Cai Jing·2026-01-05 06:07Group 1 - The core point of the news is that RunDa Medical's stock has increased by 5.02%, reaching a price of 15.70 yuan per share, with a trading volume of 329 million yuan and a turnover rate of 3.55%, resulting in a total market capitalization of 9.478 billion yuan [1] - RunDa Medical, established on January 6, 1999, and listed on May 27, 2015, is located in Shanghai and primarily provides in vitro diagnostic products and professional technical support to various medical laboratories through its comprehensive service system [1] - The company's main revenue composition includes reagents and other consumables at 93.50%, instruments at 3.70%, software development and services at 2.67%, and other supplementary sources at 0.14% [1] Group 2 - From the perspective of fund holdings, one fund under Dongcai has a significant position in RunDa Medical, with the Dongcai Vision Growth Mixed Fund A (018088) increasing its holdings by 21,600 shares in the third quarter, totaling 50,300 shares, which represents 4.81% of the fund's net value, making it the fifth-largest holding [2] - The Dongcai Vision Growth Mixed Fund A (018088) was established on April 11, 2023, with a latest scale of 12.0303 million yuan, achieving a year-to-date return of 28.7%, ranking 3300 out of 8155 in its category [2] - The fund manager, Sun Chenyang, has been in position for 2 years and 271 days, with the fund's total asset size at 33.8361 million yuan, achieving a best return of 38.97% and a worst return of -28.98% during his tenure [3]